Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease

Neurology

Volumn 55, Issue 9, 2000, Pages 1396-1397

  Chapman, T ^b   McKeel Jr , D W ^a   Morris, John C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; PRION PROTEIN; PROTEIN 14 3 3; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION;

EID: 0034649443     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.55.9.1396     Document Type: Article

References (10)

1. Transmission to mice indicates the 'new variant' CJD is caused by the BSE agent
2. Human prion disease
3. Prion infections in Creutzfeldt-Jakob disease and its variants
4. Infectious cerebral amyloidoses: Creutzfeldt-Jakob disease and the Gerstmann-Straussler-Scheinker syndrome
5. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
6. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease
7. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
8. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease
9. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease
10. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders